Hervy E. Averette

492 total citations
18 papers, 377 citations indexed

About

Hervy E. Averette is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hervy E. Averette has authored 18 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hervy E. Averette's work include Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (3 papers) and Virus-based gene therapy research (2 papers). Hervy E. Averette is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (3 papers) and Virus-based gene therapy research (2 papers). Hervy E. Averette collaborates with scholars based in United States, Germany and Switzerland. Hervy E. Averette's co-authors include James P. Perras, Manuel Peñalver, Bernd‐Uwe Sevin, Bernd‐Uwe Sevin, Daniel Donato, Ossi R. Koechli, Roberto Angioli, Hoa N. Nguyen, Mike F. Janicek and Albert Steren and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

Hervy E. Averette

18 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervy E. Averette United States	13	140	118	113	95	61	18	377
H. Würz Germany	11	67 0.5×	149 1.3×	74 0.7×	55 0.6×	58 1.0×	24	350
G. C. Torre Italy	5	69 0.5×	104 0.9×	153 1.4×	56 0.6×	78 1.3×	8	325
Y Tenjin Japan	11	117 0.8×	184 1.6×	101 0.9×	64 0.7×	63 1.0×	38	488
Takuhei Yokoyama Japan	11	117 0.8×	174 1.5×	141 1.2×	107 1.1×	40 0.7×	17	399
Ivana Rizzuto United Kingdom	10	150 1.1×	141 1.2×	173 1.5×	70 0.7×	46 0.8×	24	457
Megan I. Samuelson United States	13	98 0.7×	169 1.4×	123 1.1×	154 1.6×	31 0.5×	29	495
Annie-France Bringuier France	12	89 0.6×	170 1.4×	63 0.6×	34 0.4×	71 1.2×	15	390
B Ferry United Kingdom	10	100 0.7×	188 1.6×	75 0.7×	99 1.0×	43 0.7×	13	572
Ignacio Mariscal Mexico	5	56 0.4×	199 1.7×	46 0.4×	112 1.2×	62 1.0×	7	382
B.J. Monk United States	11	135 1.0×	71 0.6×	191 1.7×	135 1.4×	104 1.7×	57	367

Countries citing papers authored by Hervy E. Averette

Since Specialization

Citations

This map shows the geographic impact of Hervy E. Averette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervy E. Averette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervy E. Averette more than expected).

Fields of papers citing papers by Hervy E. Averette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervy E. Averette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervy E. Averette. The network helps show where Hervy E. Averette may publish in the future.

Co-authorship network of co-authors of Hervy E. Averette

This figure shows the co-authorship network connecting the top 25 collaborators of Hervy E. Averette. A scholar is included among the top collaborators of Hervy E. Averette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervy E. Averette. Hervy E. Averette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Averette, Hervy E., et al.. (2001). HISTORY OF GYNECOLOGIC ONCOLOGY SUBSPECIALTY. Surgical Clinics of North America. 81(4). 747–751. 17 indexed citations

Janicek, Mike F., Bernd‐Uwe Sevin, James P. Perras, et al.. (1997). In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma. Gynecologic Oncology. 64(1). 18–25. 31 indexed citations

Rodriguez, Michael, Bernd‐Uwe Sevin, James P. Perras, et al.. (1995). Paclitaxel: A Radiation Sensitizer of Human Cervical Cancer Cells. Gynecologic Oncology. 57(2). 165–169. 45 indexed citations

Janicek, Mike F., Bernd‐Uwe Sevin, Hoa N. Nguyen, & Hervy E. Averette. (1995). Combination Anti-Gene Therapy Targeting c-myc and p53 in Ovarian Cancer Cell Lines. Gynecologic Oncology. 59(1). 87–92. 15 indexed citations

Averette, Hervy E., et al.. (1994). The Role of Prophylactic Oophorectomy in Cancer Prevention. Gynecologic Oncology. 55(3). S38–S41. 28 indexed citations

Sevin, Bernd‐Uwe, et al.. (1994). Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP–cell viability assay. Anti-Cancer Drugs. 5(1). 24–30. 27 indexed citations

Sevin, Bernd‐Uwe, James P. Perras, Hervy E. Averette, Daniel Donato, & Manuel Peñalver. (1993). Chemosensitivity testing in ovarian cancer. Cancer. 71(S4). 1613–1620. 40 indexed citations

Koechli, Ossi R., Barry P. Avner, Bernd‐Uwe Sevin, et al.. (1993). Application of the adenosine triphosphate‐cell viability assay in human breast cancer chemosensitivity testing: A report on the first results. Journal of Surgical Oncology. 54(2). 119–125. 20 indexed citations

Peñalver, Manuel, et al.. (1993). Functional characteristics and follow‐up of the continent ileal colonic urinary reservoir: Miami pouch. Cancer. 71(S4). 1667–1672. 10 indexed citations

10.

Angioli, Roberto, Michael Untch, Bernd‐Uwe Sevin, et al.. (1993). Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells. Cancer. 71(9). 2776–2781. 7 indexed citations

11.

Sevin, Bernd‐Uwe, et al.. (1992). In vitro evaluation of a novel chemotherapeutic agent, adozelesin, in gynecologic-cancer cell lines. Cancer Chemotherapy and Pharmacology. 30(1). 37–42. 7 indexed citations

12.

Angioli, Roberto, Bernd‐Uwe Sevin, James P. Perras, et al.. (1992). Rationale of Combining Radiation and Interferon for the Treatment of Cervical Cancer. Oncology. 49(6). 445–449. 11 indexed citations

13.

Sevin, Bernd‐Uwe, et al.. (1992). The use of ATP bioluminescence assay and flow cytometry in predicting radiosensitivity of uterine cancer cell lines: Correlation of radiotoxicity and cell cycle kinetics. Gynecologic Oncology. 46(1). 88–96. 5 indexed citations

14.

Sevin, Bernd‐Uwe, et al.. (1991). In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line. Gynecologic Oncology. 43(1). 37–45. 19 indexed citations

15.

Houdek, Pavel V., James G. Schwade, André Abitbol, et al.. (1991). Optimization of high dose-rate cervix brachytherapy; Part I: Dose distribution. International Journal of Radiation Oncology*Biology*Physics. 21(6). 1621–1625. 14 indexed citations

16.

Averette, Hervy E., et al.. (1990). Ovarian carcinoma.Advances in diagnosis, staging, and treatment. Cancer. 65(S3). 703–708. 32 indexed citations

17.

Peñalver, Manuel, et al.. (1990). Stage III and stage IV endometrial carcinoma: A review of 41 cases. Gynecologic Oncology. 38(2). 210–215. 25 indexed citations

18.

Boike, Guy M., Edgar Petru, Bernd‐Uwe Sevin, et al.. (1990). Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecologic Oncology. 38(3). 315–322. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact